circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG / MAPK / ERK Axis
Journal of Cellular and Molecular Medicine · 2026-07 · 30 (13)
DOI: 10.1111/jcmm.71230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 06.07.2026. Verfasst von Leyi Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreas Center, Guangdong Institute of Cardiovascular Diseases, Guangdong Provincial People's Hospital (Guangdong Academy of Medical S…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Forkhead Transcription Factors, Pancreatic Neoplasms, RNA, Circular. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China, Guangzhou High-level Key Clinical Specialty Construction Project.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are indispensable for triggering pancreatic ductal adenocarcinoma (PDAC) progression. However, the specific biological processes and mechanisms by which circRNAs influence PDAC remain largely unknown. Here, we reported that circFOXP1 is a critical promoter of PDAC progression, exhibiting marked upregulation in patient tumour tissues that correlates with advanced TNM stage and poor prognosis. Functional studies demonstrate that circFOXP1 knockdown significantly suppresses PDAC cell proliferation, migration, and invasion in vitro and in vivo. Mechanistically, circFOXP1 acts as a molecular sponge for miR‐320b, leading to the upregulation of epidermal growth factor receptor (EGFR) ligand Epiregulin (EREG) and the subsequent activation of the MAPK/ERK signalling pathway, which is crucial for maintaining the aggressive phenotype of PDAC. The blockade of EREG using neutralizing antibodies in vivo substantially abrogates circFOXP1‐induced tumorigenesis. Our findings underscore the potential of circFOXP1 as a novel biomarker and propose a novel therapeutic target to improve survival in PDAC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreas Center, Guangdong Institute of Cardiovascular Diseases, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, People's…
- Department of Pancreatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
- Department of Gastrointestinal, Hernia, and Abdominal Wall Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, People's Republic of China.
- Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
ORCID-Profile: Xiaofeng Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province, China
- Guangzhou High-level Key Clinical Specialty Construction Project
- Young Talent Support Project of Guangzhou Association for Science and Technology
- Science and Technology Projects in Guangzhou
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Huang, L., Su, D., He, R., Zhong, B., Wang, Q., Feng, F., Li, J., Cao, J., Zhou, Q., & Guo, X. (2026). circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG / MAPK / ERK Axis. Journal of Cellular and Molecular Medicine, 30(13). https://doi.org/10.1111/jcmm.71230
Vancouver
Huang L, Su D, He R, Zhong B, Wang Q, Feng F, et al. circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG / MAPK / ERK Axis. Journal of Cellular and Molecular Medicine. 2026;30(13). doi:10.1111/jcmm.71230
BibTeX
@article{Huang2026,
author = {Huang, Leyi and Su, Dan and He, Rihua and Zhong, Bingzheng and Wang, Qiang and Feng, Fuxu and Li, Jingwen and Cao, Jie and Zhou, Quanbo and Guo, Xiaofeng},
title = {circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG / MAPK / ERK Axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {13},
doi = {10.1111/jcmm.71230}
}
EUVIMED